IFNG and breast carcinoma: As expected, IL‐18 induced IFNG gene alteration has been increased dramatically in metastatic breast carcinoma (Figure 2B), which denotes the failure of IL‐18 to stop genetic alteration of IFNG in advanced breast cancer.